Clinical trial · Interventional
Efficacy of Serratus Anterior Plane Block With Dexmedetomidine During Breast Surgery
Efficacy of Single Level Versus Bilevel Serratus Anterior Plane Block With Dexmedetomidine During Breast Cancer Surgery
NCT05361837CI-TRIAL-00116280recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to compare single level serratus block versus bilevel serratus block with and without dexmedetomidine in cancer patients undergoing modified radical mastectomy for breast cancer regarding pain control and possible side effects.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Analgesia | — | UNRESOLVED | — |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Bilevel serratus anterior plane block | Procedure | — | UNRESOLVED |
| Bilevel serratus anterior plane block with dexmedetomidine | Procedure | — | UNRESOLVED |
| Single level serratus anterior plane block | Procedure | — | UNRESOLVED |
| Single level serratus anterior plane block with dexmedetomidine | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- type
- ACTIVE_COMPARATOR
- label
- Single level serratus anterior plane block
- description
- the allocated patients will receive single injection serratus anterior plane block at the level of third rib with local anesthetics only
- interventionNames
- Procedure: Single level serratus anterior plane block
- type
- EXPERIMENTAL
- label
- Single level serratus anterior plane block with dexmedetomidine
- description
- the allocated patients will receive single injection serratus anterior plane block at the level of third rib with local anesthetics and dexmedetomidine
- interventionNames
- Procedure: Single level serratus anterior plane block with dexmedetomidine
- type
- EXPERIMENTAL
- label
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * patients scheduled for modified radical mastectomy, * Age 18-65 years, * ASA I-II Exclusion Criteria: * patient refusal, * coagulation defects, * abnormal kidney or liver functions, * local infection at site of injection.
References
Publications (0)
Data not yet available
No reference posted for this study.